Mount Vernon Hospital
Welcome,         Profile    Billing    Logout  
 2 Trials 
5 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Makris, Andreas
TRAK-ER, NCT04985266: A Trial of Early Detection of Molecular Relapse With Circulating Tumour DNA Tracking and Treatment With Palbociclib Plus Fulvestrant Versus Standard Endocrine Therapy in Patients With ER Positive HER2 Negative Breast Cancer

Recruiting
2
1100
Europe
Palbociclib 125Mg Tab, Fulvestrant injection, Tamoxifen, Letrozole, Exemestane, Anastrozole
Royal Marsden NHS Foundation Trust, Pfizer, AstraZeneca, Institute of Cancer Research, United Kingdom, UNICANCER, Gustave Roussy, Cancer Campus, Grand Paris, Invitae Corporation
ER+ Breast Cancer, HER2-negative Breast Cancer
09/27
09/30
Sharma, Anand K
RAMPART, NCT03288532 / 2017-002329-39: Renal Adjuvant MultiPle Arm Randomised Trial

Hourglass Oct 2023 - Dec 2023 : From RAMPART trial with or without in combination with tremelimumab
Recruiting
3
1750
Europe
Durvalumab, Tremelimumab
University College, London, AstraZeneca, Kidney Cancer UK, Cancer Research UK
Renal Cell Carcinoma
07/24
12/34
PEAR-TREE2, NCT06264479: Prospective Evaluation of AI R&D Tool for Patient Stratification: a Trial for Renal Immuno-oncology Model Experimental Evaluation 2

Not yet recruiting
N/A
200
Europe
Biopsy
Ourotech, Inc., Royal Free Hospital NHS Foundation Trust, Cambridge University Hospitals NHS Trust, East & North Herts NHS Trust, Imperial College Healthcare NHS Trust
Kidney Cancer, Renal Cell Cancer Metastatic
09/28
03/29
IRONMAN, NCT03151629: International Registry for Men With Advanced Prostate Cancer

Recruiting
N/A
5000
Europe, Canada, US, RoW
Standard of Care
Prostate Cancer Clinical Trials Consortium
Prostate Cancer
01/29
01/29
Makris, PI: Dr Andreas
TRAK-ER, NCT04985266: A Trial of Early Detection of Molecular Relapse With Circulating Tumour DNA Tracking and Treatment With Palbociclib Plus Fulvestrant Versus Standard Endocrine Therapy in Patients With ER Positive HER2 Negative Breast Cancer

Recruiting
2
1100
Europe
Palbociclib 125Mg Tab, Fulvestrant injection, Tamoxifen, Letrozole, Exemestane, Anastrozole
Royal Marsden NHS Foundation Trust, Pfizer, AstraZeneca, Institute of Cancer Research, United Kingdom, UNICANCER, Gustave Roussy, Cancer Campus, Grand Paris, Invitae Corporation
ER+ Breast Cancer, HER2-negative Breast Cancer
09/27
09/30

Download Options